1. Guelpa G, Marie A. La lutte contre l'épilepsie par la désintoxication et par la réeducation alimentaire [The fight against epilepsy by detoxification and by food reeducation]. Rev Ther Med Chir [Paris] 1911;78:8-13.

2. Geyelin HR. Fasting as a method for treating epilepsy. Med Rec 1921;99:1037-1039.

3. Wilder RM. The effects of ketonemia on the course of epilepsy. Mayo Clin Proc 1921;2:307-308.

4. Talbot FB, Metcalf KM, Moriarty ME. Epilepsy: chemical investigations of rational treatment by production of ketosis. Am J Dis Child 1927;33:218-225.

5. Kety SS. The general metabolism of the brain in vivo. In: Richter D (ed.). Metabolism of the Nervous System. Pergamon, London, 1957, pp. 221-237.

6. Owen OE, Morgan AP, Kemp HG, Sullivan JM, Herrera MG, Cahill GF Jr. Brain metabolism during fasting. J Clin Invest 1967;46:1589-1595.

7. Edmond J. Energy metabolism in developing brain cells. Can J Physiol Pharmacol 1992;70 (Suppl):S118-S129.

8. Cahill GF Jr. Starvation in man. N Engl J Med 1970;282:668-675.

9. Huttenlocher PR. Ketonemia and seizures: metabolic and anticonvulsant effects of two ketogenic diets in childhood epilepsy. Pediatr Res 1976;10:536-540.

10. Cahill GF Jr, Herrera MG, Morgan AP, Soeldner JS, Steinke J, Levy PL, Reichard GA Jr, Kipnis DM. Hormone-fuel interrelationships during fasting. J Clin Invest 1966;45:1751-1769.

11. Williamson DH, Whitelaw E. Physiological aspects of the regulation of ketogenesis. Biochem Soc Symp 1978;43:137-161.

12. Freund G. The calorie deficiency hypothesis of ketogenesis tested in man. Metabolism 1965;14:985-990.

13. Seymour KJ, Bluml S, Sutherling J, Sutherling W, Ross BD. Identification of cerebral acetone by 1H-MRS in patients with epilepsy controlled by ketogenic diet. MAGMA 1999;8:33-42.

14. Friedlander WJ. Putnam, Merritt, and the discovery of Dilantin. Epilepsia 1986;27 (Suppl 3):S1-S20.

15. McQuarrie I, Keith HM. Relationship of variations in the degree of ketonuria to occurrence of convulsions in epileptic children on ketogenic diets. Am J Dis Child 1927;34:1013-1029.

16. Helmholz HF, Keith HM. Eight years' experience with the ketogenic diet in the treatment of epilepsy. JAMA 1930;95:707-709.

17. Gilbert DL, Pyzik PL, Freeman JM. The ketogenic diet: seizure control correlates better with serum beta-hydroxybutyrate than with urine ketones. J Child Neurol 2000;15:787-790.

18. Ross DL, Swaiman KF, Torres F, Hansen J. Early biochemical and EEG correlates of the ketogenic diet in children with atypical absence epilepsy. Pediatr Neurol 1985;1:104-108.

19. Millichap JG, Jones JD, Rudis BP. Mechanism of anti-convulsant action of ketogenic diet. Am J Dis Child 1964;107:593-604.

20. Hassan AM, Keene DL, Whiting SE, Jacob PJ, Champagne JR, Humphreys P. Ketogenic diet in the treatment of refractory epilepsy in childhood. Pediatr Neurol 1999;21:548-552.

21. Appleton DB, DeVivo DC. An animal model for the ketogenic diet. Epilepsia 1974;15:211-227.

22. Uhlemann ER, Neims AH. Anticonvulsant properties of the ketogenic diet in mice. J Pharmacol Exp Ther 1972;180:231-238.

23. Bough KJ, Eagles DA. A ketogenic diet increases the resistance to pentylenetetrazole-induced seizures in the rat. Epilepsia 1999;40:138-143.

24. Bough KJ, Chen RS, Eagles DA. Path analysis shows that increasing ketogenic ratio, but not beta-hydroxybutyrate, elevates seizure threshold in the rat. Dev Neurosci 1999;21:400-406.

25. Likhodii SS, Musa K, Mendonca A, Dell C, Burnham WM, Cunnane SC. Dietary fat, ketosis, and seizure resistance in rats on the ketogenic diet. Epilepsia 2000;41:1400-1410.

26. Freeman JM, Vining EP. Seizures decrease rapidly after fasting: preliminary studies of the ketogenic diet. Arch Pediatr Adolesc Med 1999;153:946-949.

27. Stafstrom CE. Animal models of the ketogenic diet: what have we learned, what can we learn? Epilepsy Res 1999;37:241-259.

28. Hasselbalch SG, Knudsen GM, Jakobsen J, Hageman LP, Holm S, Paulson OB. Brain metabolism during short-term starvation in humans. J Cereb Blood Flow Metab 1994;14:125-131.

29. Hawkins RA, Mans AM, Davis DW. Regional ketone body utilization by rat brain in starvation and diabetes. Am J Physiol 1986;250(2 Pt 1):E169-E178.

30. Leino RL, Gerhart DZ, Duelli R, Enerson BE, Drewes LR. Diet-induced ketosis increases monocar-boxylate transporter (MCT1) levels in rat brain. Neurochem Int 2001;38:519-527.

31. Likhodii SS, Burnham WM. Ketogenic diet: does acetone stop seizures? Med Sci Monit 2002;8:HY19-HY24.

32. Persson B, Settergren G, Dahlquist G. Cerebral arterio-venous difference of acetoacetate and D-ß-hydroxybutyrate in children. Acta Paediatr Scand 1972;61:273-278.

33. Owen OE, Reichard GA Jr, Boden G, Shuman C. Comparative measurements of glucose, beta-hydroxy-butyrate, acetoacetate, and insulin in blood and cerebrospinal fluid during starvation. Metabolism 1974;23:7-14.

34. Lamers KJ, Doesburg WH, Gabreels FJ, Romsom AC, Lemmens WA, Wevers RA, Renier WO. CSF concentration and CSF/blood ratio of fuel related components in children after prolonged fasting. Clin Chim Acta 1987;167:135-145.

35. Lustig S, Niesen CE. Beta-hydroxybutyrate suppresses pentylenetetrazol (PTZ) induced seizures in young adult rats. Epilepsia 1998;39 (Suppl 6):S36.

36. Bailey DN. Detection of isopropanol in acetonemic patients not exposed to isopropanol. J Toxicol Clin Toxicol 1990;28:459-466.

37. Driver RL. Isopropyl alcohol, other ketogens, and miscellaneous agents on thresholds for electrical convulsions and diphenylhydantoin. Proc Soc Exp Biol Med 1947;64:248-251.

38. Chu N, Driver RL, Hanzlik PJ. Anticonvulsant action of isopropyl alcohol. J Pharmacol Exp Ther 1948;92:291-302.

39. Schaffarzick RW. Anticonvulsant action of isopropanol. Proc Soc Exp Biol Med 1950;74:211-215.

40. Keith HM. The effect of various factors on experimentally produced convulsions. Am J Dis Child 1931;41:532-543.

41. Keith HM. Further studies of the control of experimentally produced convulsions. J Pharmacol Exp Ther 1932;44:449-455.

42. Keith HM. Factors influencing experimentally produced convulsions. Arch Neurol Psych 1933;29:148-154.

43. Rowland LP. Introduction to first annual Merritt-Putnam Symposium, Cambridge. Epilepsia 1982;23 (Suppl 1):S1-S4.

44. Mahoney AW, Hendricks DG, Bernhard N, Sisson DV. Fasting and ketogenic diet effects on audiogenic seizures susceptibility of magnesium deficient rats. Pharmacol Biochem Behav 1983;18:683-687.

45. Thio LL, Wong M, Yamada KA. Ketone bodies do not directly alter excitatory or inhibitory hippocam-pal synaptic transmission. Neurology 2000;54:325-331.

46. Niesen CE, Ge S. The effect of ketone bodies, ß-hydroxybutyrate, and acetoacetate on acute seizure activity in hippocampal CA1 neurons. Epilepsia 1998;39 (Suppl 6):S35.

47. Rho JM, Anderson GD, Donevan SD, White HS. Acetoacetate, acetone, and dibenzylamine (a contaminant in 1-(+)-beta-hydroxybutyrate) exhibit direct anticonvulsant actions in vivo. Epilepsia 2002;43:358-361.

48. Jenney EH, Lee LD. The convulsant effect of semicarbazide. J Pharmacol Exp Ther 1951;103:349.

49. Jenney EH, Pfeiffer CC. The convulsant effect of hydrazides and the antidotal effect of anticonvulsants and metabolites. J Pharmacol Exp Ther 1958;122:110-123.

50. Kohli RP, Kishor K, Dua PR, Saxena RC. Anticonvulsant activity of some carbonyl containing compounds. Indian J Med Res 1967;55:1221-1225.

51. Postolache V, Safta L, Cuparencu B, Steiner L. Die Wirkung von Aceton auf Pentamethylentetrazol-Krämpfe [Effect of acetone upon pentamethylenetetrazole convulsions.] Arch Toxikol 1970;26:273-276.

52. Yamashita J. Convulsive seizure induced by intracerebral injection of semicarbazide (an anti-vitamin B6) in the mouse. J Nutr Sci Vitaminol (Tokyo) 1976;22:1-6.

53. Frantik E, Horvath M, Vodickova L. Effects of solvent mixtures on behaviour and seizure characteristics at the utmost additive. Act Nerv Super (Praha) 1988;30:260-264.

54. Vodickova L, Frantik E, Vodickova A. Neutrotropic effects and blood levels of solvents at combined exposures: binary mixtures of toluene, o-xylene and acetone in rats and mice. Cent Eur J Public Health 1995;3:57-64.

55. Frantik E, Vodickova L, Hornychova M, Nosek M. Pattern of inhalation exposure: blood levels and acute subnarcotic effects of toluene and acetone in rats. Cent Eur J Public Health 1996;4:226-232.

56. Likhodii SS, Snead OC, Burnham WM: The ketogenic diet. Does acetone stop seizures? 55th Annual Meeting of the Eastern Association of Electroencephalographers, New York, March 24, 2001. Clin Neurophysiol 2002;113:1365.

57. Likhodii SS, Musa K, Cunnane SC. Breath acetone as a measure of systemic ketosis assessed in a rat model of the ketogenic diet. Clin Chem 2002;48:115-120.

58. Likhodii SS, Serbanescu I, Cortez MA, Murphy P, Snead OC III, Burnham WM. Anticonvulsant properties of acetone, a brain ketone elevated by the ketogenic diet. Ann Neurol 2003;54:219-226.

Diabetes 2

Diabetes 2

Diabetes is a disease that affects the way your body uses food. Normally, your body converts sugars, starches and other foods into a form of sugar called glucose. Your body uses glucose for fuel. The cells receive the glucose through the bloodstream. They then use insulin a hormone made by the pancreas to absorb the glucose, convert it into energy, and either use it or store it for later use. Learn more...

Get My Free Ebook

Post a comment